EP0588408B1 - An ascorbic acid type developer with a particular composition - Google Patents

An ascorbic acid type developer with a particular composition Download PDF

Info

Publication number
EP0588408B1
EP0588408B1 EP19930202545 EP93202545A EP0588408B1 EP 0588408 B1 EP0588408 B1 EP 0588408B1 EP 19930202545 EP19930202545 EP 19930202545 EP 93202545 A EP93202545 A EP 93202545A EP 0588408 B1 EP0588408 B1 EP 0588408B1
Authority
EP
European Patent Office
Prior art keywords
pyrazolidone
phenyl
ascorbic acid
developing
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP19930202545
Other languages
German (de)
French (fr)
Other versions
EP0588408A1 (en
Inventor
Andriessen C/O Agfa-Gevaert N.V. Hieronymus
Lingier c/o Agfa-Gevaert N.V. Stefaan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agfa Gevaert NV
Original Assignee
Agfa Gevaert NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agfa Gevaert NV filed Critical Agfa Gevaert NV
Publication of EP0588408A1 publication Critical patent/EP0588408A1/en
Application granted granted Critical
Publication of EP0588408B1 publication Critical patent/EP0588408B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03C—PHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C5/00—Photographic processes or agents therefor; Regeneration of such processing agents
    • G03C5/26—Processes using silver-salt-containing photosensitive materials or agents therefor
    • G03C5/29—Development processes or agents therefor
    • G03C5/30—Developers

Definitions

  • the present invention relates to the field of photographic developing solutions and more particularly to a photographic developing solution having a particular combination of developing agents.
  • aqueous alkaline developer compositions containing a developing agent usually of the dihydroxybenzene type such as hydroquinone.
  • US 2,688,549 discloses the combination of a 3-pyrazolidone developing agent and of an ascorbic acid derivative.
  • GB 1,266,533 describes the combination of an p-hydroxybenzene developing agent, an ascorbic acid and sulphite ions.
  • An equally good developing activity for both surface and internal latent images is claimed in US 3,826,654 which discloses a combination of a 3-pyrazolidone, an ascorbic acid, a heterocyclic thione or thiol and an alkali iodide at a pH of at least 12.
  • the use of particular mixtures of two Phenidone type auxiliary developing agents in combination with an ascorbic acid type main developing agent caused substantially less sensitometric deterioration, namely sensitivity and gradation loss, due to pH decrease, than when only one Phenidone type auxiliary developing agent was present.
  • the ascorbic acid type developing agent is l-ascorbic acid or iso-ascorbic acid, or a salt thereof
  • the mixture of the at least two Phenidone type agents consists of a mixture 1-phenyl-3-pyrazolidone (P) and 1-phenyl-4-methyl-3-pyrazolidone (MP).
  • Preferred ascorbic acid type developing agents according to general formula (I) for use in accordance with the present invention are l-ascorbic acid and iso-ascorbic acid.
  • Other useful compounds include imino-l-ascorbic acid, 6-desoxy-l-ascorbic acid, l-rhamnoascorbic acid, l-fucoascorbic acid, d-glucoheptoascorbic acid, d-glucoascorbic acid, l-erythroascorbic acid, and their stereoisomers.
  • the developing agents can be incorporated in the developing solution in the free acid form or as a salt, preferably an alkali salt.
  • the ascorbic acid type developing agent is incorporated in the developer in a concentration ranging preferably between 0.1 and 0.6 mole/liter, corresponding to a range between 25 and 100 g/l for ascorbic acid.
  • the at least two 3-pyrazolidone type auxiliary agents are chosen from the group consisting of (a) 1-phenyl-3-pyrazolidone ("Phenidone", P), (b) 1-phenyl-4-methyl-3-pyrazolidone ("methyl-Phenidone", MP), (c) 1-phenyl-4-methyl-4'-hydroxymethyl-3-pyrazolidone("methyl-hydroxymethyl-Phenidone", MHMP), (d) 1-phenyl-4,4'-dimethyl-3-pyrazolidone ("dimethyl-Phenidone", DMP).
  • a mixture of two is chosen and the most preferred choice consists of a mixture of 1-phenyl-3-pyrazolidone ("Phenidone", P) and 1-phenyl-4-methyl-3-pyrazolidone ("methyl-Phenidone", MP) as will become clear from the examples.
  • P 1-phenyl-3-pyrazolidone
  • methyl-Phenidone MP
  • the preferred concentration of 1-phenyl-3-pyrazolidone ranges from 0.1 to 2.0 g/l
  • the preferred concentration of 1-phenyl-4-methyl-3-pyrazolidone ranges from 0.1 to 5.5 g/l.
  • the developing solution can further contain an anti-fogging agent.
  • an anti-fogging agent Many known compounds can be added as fog-inhibiting agent or stabilizer to a processing solution. Suitable examples are e.g. the heterocyclic nitrogen-containing compounds such as benzothiazolium salts, nitroimidazoles, nitrobenzimidazoles, chlorobenzimidazoles, bromobenzimidazoles, mercaptothiazoles, mercaptobenzothiazoles, mercaptobenzimidazoles, mercaptothiadiazoles, aminotriazoles, benzotriazoles (preferably 5-methyl-benzotriazole), nitrobenzotriazoles, mercaptopyrimidines, mercaptotriazines, benzothiazoline-2-thione and oxazoline-thione.
  • benzothiazolium salts such as benzothiazolium salts, nitroimidazoles, nitrobenzimidazoles, chlorobenzimidazoles
  • triazolopyrimidines such as those described in GB 1,203,757, GB 1,209,146, JA-Appl. 75-39537, and GB 1,500,278 and other compounds such as benzenethiosulphonic acid, benzenethiosulphinic acid and benzenethiosulphonic acid amide compounds.
  • a preferred compound for use in accordance with the present invention is 1-phenyl-5-mercaptotetrazole.
  • the developing solution according to the present invention preferably further contains a compound providing halide ions as development rate regulator, most preferably sodium or potassium bromide in a concentration between 0.01 and 0.2 mole/liter.
  • a compound providing halide ions as development rate regulator, most preferably sodium or potassium bromide in a concentration between 0.01 and 0.2 mole/liter.
  • Further sulphite ions can be present as antioxidant preferably as an alkali sulphite in a concentration between 0.1 and 0.8 mole/liter.
  • the alkali agent for establishing the start pH of the developer is preferably sodium or potassium hydroxide.
  • the developing solution can further contain buffering agents.
  • buffering agents include carbonate buffer, phosphate buffer, metaborate buffer, etc.
  • concentration of these buffering agents is preferably about 0.4 mole/liter.
  • the scope of the present invention further comprises a method for developing an image-wise exposed photographic material by means of the described developing solution.
  • the method of the present invention is especially useful when no replenisher solution is present for compensating the pH drop during exhaustive continuous processing.
  • a conventional fixing step washing step and drying step are performed.
  • an automatically driven processing apparatus is used.
  • the silver halide photographic materials which can be processed by the method of the present invention include all kinds of black-and-white materials, e.g. films and papers for amateur photography, films for cinematography, materials for radiographic recording and materials for graphic arts.
  • the silver halide emulsions present as photosensitive element in those photographic materials can be of any known halide composition, e.g. bromide, chloride, iodobromide, chlorobromide or chloroiodobromide emulsions.
  • the best results with the present invention are however obtained with materials containing emulsions rich in bromide, and more particularly with emulsions containing at least 70 mole % of bromide.
  • a silver halide material for microfilm application having a silver halide coverage equivalent to 3.6 g of silver nitrate per sq.m. and containing a 100% silver bromide emulsion with an average grain size of 0.3 ⁇ m was processed in a automatic processor, having a tank solution of 1 liter.
  • the decrease in development activity due to the pH decrease on exhaustive processing was simulated by comparing the sensitometry in two solutions, one adjusted to pH 10.5, the other to pH 9.9.
  • the development time applied was 20 s and the temperature was kept constant at 38 °C.
  • the basic composition of these developer solutions was : Water 600 ml K2SO3 65 g K2CO3 61 g KBr 15 g Ascorbic acid sodium salt 50 g KOH 8.5 g (pH 9.90) or KOH 16.5 g (pH 10.50) Water to make 1 l.
  • the goal of the tests described in this example was to optimize the ratio of the amounts of P and MP, which proved to be the best combination according to example 1.
  • the microfilm material used was similar as the one used in example 1.
  • the basic composition of the developing solutions was the same as the composition of example 1. Table 2 shows the results of using different ratio's of P and MP.
  • Table 2 shows that several ratio's of P and MP gave good results, namely low decrease of sensitivity and toe gradation for a change of pH from 10.50 to 9.90.
  • Table 5 shows the effects of these compounds and of their combinations on the change in sensitivity (DSENS, measured at density 1.1 + Dmin), on the change of gradation in the toe of the sensitometric curve (DGRAD t , measured between densities 0.1 + Dmin and 1.1 + Dmin) and on the change of gradation (DGRAD, measured between densities 0.5 + Dmin and 1.5 + Dmin) when changing the pH from 10.5 to 9.9.

Description

1. Field of the invention.
The present invention relates to the field of photographic developing solutions and more particularly to a photographic developing solution having a particular combination of developing agents.
2. Background of the invention.
In general, the processing of black-and-white silver halide photographic materials is performed in the order of development, fixing and washing. Development is commonly carried out with aqueous alkaline developer compositions containing a developing agent, usually of the dihydroxybenzene type such as hydroquinone.
Due to the toxicity and environmental hazards posed by the use of hydroquinone, several substitutes which are less toxic by nature have been proposed. For example the developing activity of ascorbic acid and some chemical analogues is known for quite some time in the photographic art. However ascorbic acid and derivatives are regarded as rather weak developers in the pH-range in which hydroquinone acts as a developing agent. Hence, since the first report of the developing activity of iso-ascorbic acid and its optical isomer in Berichte, Vol.67, p.1239 (1934) by Mauer et al., there have been several publications on developers containing a superadditive combination of a conventional developing agent and an ascorbic acid derivative used as auxiliary developer. So, US 2,688,549 discloses the combination of a 3-pyrazolidone developing agent and of an ascorbic acid derivative. GB 1,266,533 describes the combination of an p-hydroxybenzene developing agent, an ascorbic acid and sulphite ions. An equally good developing activity for both surface and internal latent images is claimed in US 3,826,654 which discloses a combination of a 3-pyrazolidone, an ascorbic acid, a heterocyclic thione or thiol and an alkali iodide at a pH of at least 12.
However developing solutions containing ascorbic acid derivatives which are themselves excellent antioxidants have poor resistance against air oxidation and can not be left in continuous transport automatic processors for several days without undergoing a dramatic decrease in developing activity. This decrease in developing activity is mainly due to the decrease of the pH. The continuous contact of these solutions with oxygen of the air consumes an amount of developing agent and will lead in the case of ascorbic acid derivatives to a pH decrease. Developing silver on the other hand consumes also an amount of developing agent leading also to a pH decrease.
Thus, in continuous automatic processing, especially in the case without replenishment by fresh developer, a gradual pH decrease will always occur, resulting in a less active developing system causing severe lowering of sensitivity and gradation for a given constant development time. However it is evident that this is a very undesirable situation and that a solution has to be sought for minimizing these adversive effects.
It is an object of the present invention to provide a photographic developing solution containing an ascorbic acid type developing agent, the development activity of which is only moderately affected by the pH decrease resulting from continuous processing without replenishment.
It is a further object of the present invention to provide a method for developing an image-wise exposed silver halide emulsion layer to a black-and-white image using such a particular developing solution.
3. Summary of the invention.
The objects of the present invention are realized by providing a developing solution comprising :
  • (1) an ascorbic acid type developing agent corresponding to general formula (I), or a salt of it : wherein
  • X represents an oxygen atom or an imino group, and
  • n represents a positive integer from 1 to 4, and
  • R represents a hydroxy group when n is 1, and R represents a hydroxy group or a hydrogen atom when n is 2 to 4.
  • (2) a mixture of at least two 3-pyrazolidone type developing agents chosen from the group consisting of:
  • (a) 1-phenyl-3-pyrazolidone ("Phenidone", P),
  • (b) 1-phenyl-4-methyl-3-pyrazolidone ("methyl-Phenidone", MP),
  • (c) 1-phenyl-4-methyl-4'-hydroxymethyl-3-pyrazolidone ("methyl-hydroxymethyl-Phenidone", MHMP),
  • (d) 1-phenyl-4,4'-dimethyl-3-pyrazolidone ("dimethyl-Phenidone", DMP).
    • It was surprisingly found that the use of particular mixtures of two Phenidone type auxiliary developing agents in combination with an ascorbic acid type main developing agent caused substantially less sensitometric deterioration, namely sensitivity and gradation loss, due to pH decrease, than when only one Phenidone type auxiliary developing agent was present. In a preferred embodiment the ascorbic acid type developing agent is l-ascorbic acid or iso-ascorbic acid, or a salt thereof, and the mixture of the at least two Phenidone type agents consists of a mixture 1-phenyl-3-pyrazolidone (P) and 1-phenyl-4-methyl-3-pyrazolidone (MP).
    4. Detailed description of the invention.
    Preferred ascorbic acid type developing agents according to general formula (I) for use in accordance with the present invention are l-ascorbic acid and iso-ascorbic acid. Other useful compounds include imino-l-ascorbic acid, 6-desoxy-l-ascorbic acid, l-rhamnoascorbic acid, l-fucoascorbic acid, d-glucoheptoascorbic acid, d-glucoascorbic acid, l-erythroascorbic acid, and their stereoisomers. The developing agents can be incorporated in the developing solution in the free acid form or as a salt, preferably an alkali salt.
    The ascorbic acid type developing agent is incorporated in the developer in a concentration ranging preferably between 0.1 and 0.6 mole/liter, corresponding to a range between 25 and 100 g/l for ascorbic acid.
    The at least two 3-pyrazolidone type auxiliary agents are chosen from the group consisting of (a) 1-phenyl-3-pyrazolidone ("Phenidone", P), (b) 1-phenyl-4-methyl-3-pyrazolidone ("methyl-Phenidone", MP), (c) 1-phenyl-4-methyl-4'-hydroxymethyl-3-pyrazolidone("methyl-hydroxymethyl-Phenidone", MHMP), (d) 1-phenyl-4,4'-dimethyl-3-pyrazolidone ("dimethyl-Phenidone", DMP). In a preferred embodiment a mixture of two is chosen and the most preferred choice consists of a mixture of 1-phenyl-3-pyrazolidone ("Phenidone", P) and 1-phenyl-4-methyl-3-pyrazolidone ("methyl-Phenidone", MP) as will become clear from the examples. In this embodiment the preferred concentration of 1-phenyl-3-pyrazolidone ranges from 0.1 to 2.0 g/l, and the preferred concentration of 1-phenyl-4-methyl-3-pyrazolidone ranges from 0.1 to 5.5 g/l.
    The developing solution can further contain an anti-fogging agent. Many known compounds can be added as fog-inhibiting agent or stabilizer to a processing solution. Suitable examples are e.g. the heterocyclic nitrogen-containing compounds such as benzothiazolium salts, nitroimidazoles, nitrobenzimidazoles, chlorobenzimidazoles, bromobenzimidazoles, mercaptothiazoles, mercaptobenzothiazoles, mercaptobenzimidazoles, mercaptothiadiazoles, aminotriazoles, benzotriazoles (preferably 5-methyl-benzotriazole), nitrobenzotriazoles, mercaptopyrimidines, mercaptotriazines, benzothiazoline-2-thione and oxazoline-thione. Other classes include triazolopyrimidines such as those described in GB 1,203,757, GB 1,209,146, JA-Appl. 75-39537, and GB 1,500,278 and other compounds such as benzenethiosulphonic acid, benzenethiosulphinic acid and benzenethiosulphonic acid amide compounds. A preferred compound for use in accordance with the present invention is 1-phenyl-5-mercaptotetrazole.
    The developing solution according to the present invention preferably further contains a compound providing halide ions as development rate regulator, most preferably sodium or potassium bromide in a concentration between 0.01 and 0.2 mole/liter. Further sulphite ions can be present as antioxidant preferably as an alkali sulphite in a concentration between 0.1 and 0.8 mole/liter.
    The alkali agent for establishing the start pH of the developer is preferably sodium or potassium hydroxide.
    The developing solution can further contain buffering agents. Suitable buffer systems include carbonate buffer, phosphate buffer, metaborate buffer, etc. The concentration of these buffering agents is preferably about 0.4 mole/liter.
    Other adjuvants well known to those skilled in the art can be incorporated into the developer solution. A survey of conventional developer addenda is given by Grant Haist in "Modern Photographic Processing" - John Wiley and Sons - New York (1979) p. 220-224. Examples of such addenda include complexing agents for calcium and magnesium ions, present in hard water, e.g. ethylenediaminetetraacetic acid and analogous compounds. Further can be present anti-foaming agents,
    surface-active agents, biocides, thickening agents like polystyrene sulphonate and antioxidants like benzoate and cyclodextrine. The developing liquid can contain so-called anti-sludge agents in order to reduce dirt streaks on developed photographic material. Finally the solution can contain development accelerating agents like polyalkyleneoxides and alkanolamines and hardening agents including latent hardeners.
    The scope of the present invention further comprises a method for developing an image-wise exposed photographic material by means of the described developing solution. The method of the present invention is especially useful when no replenisher solution is present for compensating the pH drop during exhaustive continuous processing.
    After development a conventional fixing step, washing step and drying step are performed. Preferably an automatically driven processing apparatus is used.
    The silver halide photographic materials which can be processed by the method of the present invention include all kinds of black-and-white materials, e.g. films and papers for amateur photography, films for cinematography, materials for radiographic recording and materials for graphic arts. The silver halide emulsions present as photosensitive element in those photographic materials can be of any known halide composition, e.g. bromide, chloride, iodobromide, chlorobromide or chloroiodobromide emulsions. The best results with the present invention are however obtained with materials containing emulsions rich in bromide, and more particularly with emulsions containing at least 70 mole % of bromide.
    The following examples illustrate the present invention without however limiting it thereto.
    EXAMPLES Example 1
    A silver halide material for microfilm application having a silver halide coverage equivalent to 3.6 g of silver nitrate per sq.m. and containing a 100% silver bromide emulsion with an average grain size of 0.3 µm was processed in a automatic processor, having a tank solution of 1 liter. The decrease in development activity due to the pH decrease on exhaustive processing was simulated by comparing the sensitometry in two solutions, one adjusted to pH 10.5, the other to pH 9.9. The development time applied was 20 s and the temperature was kept constant at 38 °C. The basic composition of these developer solutions was :
    Water 600 ml
    K2SO3 65 g
    K2CO3 61 g
    KBr 15 g
    Ascorbic acid sodium salt 50 g
    KOH 8.5 g (pH 9.90)
        or
    KOH 16.5 g (pH 10.50)
    Water to make 1 l.
    The following derivatives of 3-pyrazolidone were added in amounts according to table 1 : 1-phenyl-3-pyrazolidone (P), 1-phenyl-4-methyl-3-pyrazolidone (MP) and 1-phenyl-4-methyl-4'-hydroxymethyl-3-pyrazolidone (MHMP) and several mixtures of these compounds. Table I shows the effects of these compounds and of their combinations on the sensitivity (SENS, measured at density 1.1 + Dmin) and on the gradation in the toe of the sensitometric curve (GRADt, measured between densities 0.1 + Dmin and 1.1 + Dmin). In this table the difference of these parameters (DSENS, DGRADt) when changing the pH from 10.5 to 9.9 is also shown.
    P MP MHMP pH=10.50 PH=9.90 pH 10.5→9.9
    (g/l) (g/l) (g/l) SENS GRADt SENS GRADt DSENS DGRADt
    0.5 - - 125 1.86 116 1.71 -9 -0.15
    1.5 - - 139 1.95 130 1.76 -9 -0.19
    - 1 - 133 1.96 114 1.61 -19 -0.35
    - 2.5 - 144 1.92 134 1.82 -10 -0.10
    - - 2 132 1.92 117 1.64 -15 -0.28
    - - 4 140 1.94 132 1.81 -8 -0.13
    0.5 1 - 136 2.04 132 1.93 -4 -0.11
    1.5 2.5 - 141 1.96 139 1.92 -2 -0.04
    0.5 - 2 138 1.96 126 1.81 -12 -0.15
    1.5 - 4 145 1.95 139 1.89 -6 -0.06
    - 1 2 137 1.95 128 1.81 -9 -0.14
    - 2.5 4 149 1.92 138 1.81 -11 -0.11
    The results of table 1 show that the combinations of two Phenidone type developing agents give better results than their separate application. The combination of 1-phenyl-3-pyrazolidone (P) and 1-phenyl-4-methyl-3-pyrazolidone (MP) shows the best result, i.e. the lowest decrease of sensitivity and gradation when changing the pH from 10.50 to 9.90.
    Example 2
    The goal of the tests described in this example was to optimize the ratio of the amounts of P and MP, which proved to be the best combination according to example 1. The microfilm material used was similar as the one used in example 1. The basic composition of the developing solutions was the same as the composition of example 1. Table 2 shows the results of using different ratio's of P and MP.
    P MP pH=10.50 PH=9.90 pH 10.5->9.9
    (g/l) (g/l) SENS GRADt SENS GRADt DSENS DGRADt
    0.5 1.0 138 1.93 127 1.77 -11 -0.16
    0.5 1.5 142 1.92 133 1.81 -9 -0.11
    0.5 2.0 141 1.91 138 1.88 -3 -0.03
    1.0 1.0 143 1.95 134 1.81 -9 -0.14
    1.0 1.5 145 1.95 136 1.84 -9 -0.11
    1.0 2.0 145 1.94 140 1.89 -5 -0.05
    1.5 1.0 145 1.94 138 1.86 -7 -0.08
    1.5 1.5 147 1.95 141 1.91 -6 -0.04
    1.5 2.0 147 1.94 142 1.89 -5 -0.05
    2.0 2.5 149 1.89 141 1.85 -8 -0.04
    Table 2 shows that several ratio's of P and MP gave good results, namely low decrease of sensitivity and toe gradation for a change of pH from 10.50 to 9.90. The combination of 0.5 g/l of 1-phenyl-3-pyrazolidone (P) and 2 g/l 1-phenyl-4-methyl-3-pyrazolidone (MP) was the best but the ratio proved to be not critical.
    Example 3
    The same silver bromide film and the same basic developing solution as described in example 1 were used. The development proceeded at 5 different developing times. In one developer, 1.5 g/l 1-phenyl-3-pyrazolidine (P) was added and in the other 0.5 g/l 1-phenyl-3-pyrazolidine (P) together with 1 g/l 1-phenyl-4-methyl-3-pyrazolidine (MP) was used. Table 3 shows the change in sensitivity (1.1 + Dmin), change in toe gradation (DGRADt) (measured between 0.1 + Dmin and 1.1 + Dmin) and change in straight part gradation (DGRAD) (measured between 0.5 + Dmin and 1.5 + Dmin) when the pH of developer was decreased from 10.50 to 9.90.
    time (s) DSENS DGRADt DGRAD
    1.5 g/l P 14 -10.0 -0.18 -0.315
    18 -6.0 -0.13 -0.15
    22 -8.5 -0.13 -0.14
    26 -4.5 -0.08 -0.16
    30 -3.5 -0.11 -0.11
    0.5 g/l P + 1 g/l MP 14 -9.0 -0.145 -0.27
    18 -1.0 -0.2 +0.015
    22 -1.5 -0.03 +0.04
    26 -1.0 -0.07 +0.04
    30 -1.5 -0.08 +0.07
    For the same amount of 3-pyrazolidone derivatives (this is molar even less), the decrease of the sensitometric values was much less for the combination of the two developing agents in comparison to the use of 1-phenyl-3-pyrazolidone alone, at least at developing times greater than 14 s. Moreover, the gradation measured between 0.5 + Dmin and 1.5 + Dmin, was even slightly increased when lowering the pH from 10.50 to 9.90.
    Example 4
    The same silver bromide film as described in example 1 and 3 and a similar developing solution as described in example 1 was used. This time the basic developer composition was adjusted to pH 10.70. In the first developer, 0.5 g/l 1-phenyl-3-pyrazolidone (P) together with 2 g/l 1-phenyl-4-methyl-3-pyrazolidone (MP) was added. In the second developer, 2.35 g/l of 1-phenyl-3-pyrazolidone (P) alone was added, corresponding to an equimolar amount of developer as in the first developer. In the third developer, an equimolar amount of 1-phenyl-4-methyl-3-pyrazolidone (MP) alone, corresponding to 2.35 g/l, was added. The development was performed in a low volume processor at 38 °C in 20 s.
    In each developer, 9 m2/l film was processed, without replenishment by fresh developer. The pH decreased in all cases from 10.70 to 9.92. Table 4 shows the sensitometric results after processing of respectively 0, 3, 6 and 9 m2/l film : minimum density (Dmin), sensitivity (SENS) (measured at 1.1 + Dmin) and toe gradation (GRADt) (measured between 0.1 and 1.1 + Dmin).
    m2/l Dmin SENS GRADt
    Developer 1: 0.5 g/l P 2 g/l MP 0 8 135 1.81
    3 8 134 1.77
    6 8 131 1.76
    9 8 120 1.58
    Developer 2: 2.35 g/l P 0 9 139 1.79
    3 9 131 1.63
    6 9 126 1.59
    9 10 121 1.53
    Developer 3: 2.55 g/l MP 0 11 138 1.74
    3 10 128 1.65
    6 10 122 1.56
    9 9 113 1.43
    The results show that a mixture of 0.5 g/l 1-phenyl-3-pyrazolidone (P) together with 2 g/l 1-phenyl-4-methyl-3-pyrazolidone (MP) (developer 1) is preferable above an equimolar amount of 1-phenyl-3-pyrazolidone (2.35 g/l P ; developer 2) alone or an equimolar amount of 1-phenyl-4-methyl-3-pyrazolidone (2.55 g/l MP ; developer 3) alone. Developer 1 showed a lower decrease of sensitivity and toe gradation and moreover gave rise to a lower Dmin in comparison with developer 2 and 3.
    Example 5
    The same silver bromide film and the same basic developing solution as described in example 1 were used. The decrease in development activity due to the pH decrease on exhaustive processing was simulated by comparing the sensitometry in two solutions, one adjusted to pH 10.5, the other to pH 9.9. The development time applied was 20 s and the temperature was kept constant at 38 °C. The following derivatives of 2-pyrazolidone were added in amounts according to table 5 : 1-phenyl-3-pyrazolidone (P) and 1-phenyl-4,4'-dimethyl-3-pyrazolidone(DMP). Table 5 shows the effects of these compounds and of their combinations on the change in sensitivity (DSENS, measured at density 1.1 + Dmin), on the change of gradation in the toe of the sensitometric curve (DGRADt, measured between densities 0.1 + Dmin and 1.1 + Dmin) and on the change of gradation (DGRAD, measured between densities 0.5 + Dmin and 1.5 + Dmin) when changing the pH from 10.5 to 9.9.
    P (g/l) DMP (g/l) DSENS DGRADt DGRAD
    0.5 0 - 4.5 - 12.5 - 13
    1.5 0 - 5.5 - 6.5 - 8
    0 0.5 - 11.5 - 14.5 - 7.5
    0 1 - 13 - 20 - 20.5
    0.5 0.5 - 4 - 7 - 4
    0.5 1 - 4.5 - 5 - 2
    1.5 0.5 - 2.5 - 13.5 - 15
    1.5 1 - 2 - 1.5 - 0.5
    The results of table 1 show that the combination of 1-phenyl-3-pyrazolidone (P) and 1-phenyl-4,4'-dimethyl-3-pyrazolidone (DMP) give better results than their separate application, as was also found in example 1. The best results are obtained with 1.5 g/l P in combination with 1 g/l DMP.

    Claims (8)

    1. Photographic developing solution comprising :
      (1) an ascorbic acid type developing agent corresponding to general formula (I), or a salt of it : wherein
      X represents an oxygen atom or an imino group, and
      n represents a positive integer from 1 to 4, and
      R represents a hydroxy group when n is 1, and R represents a hydroxy group or a hydrogen atom when n is 2 to 4.
      (2) a mixture of at least two 3-pyrazolidone type developing agents chosen from the group consisting of :
      (a) 1-phenyl-3-pyrazolidone,
      (b) 1-phenyl-4-methyl-3-pyrazolidone,
      (c) 1-phenyl-4-methyl-4'-hydroxymethyl-3-pyrazolidone,
      (d) 1-phenyl-4,4'-dimethyl-3-pyrazolidone.
    2. Developing solution according to claim 1 wherein said ascorbic acid type developing agent is l-ascorbic acid or iso-ascorbic acid or a salt thereof.
    3. Developing solution according to claim 1 or 2 wherein said ascorbic acid type developing agent is present in a concentration between 0.1 and 0.6 mole/l.
    4. Developing solution according to any of claims 1 to 3 wherein said mixture of at least two 3-pyrazolidone type developing agents is a mixture of 1-phenyl-3-pyrazolidone and of 1-phenyl-4-methyl-3-pyrazolidone.
    5. Developing solution according to claim 4 wherein said 1-phenyl-3-pyrazolidone is present in a concentration between 0.1 and 2.0 g/l, and said 1-phenyl-4-methyl-3-pyrazolidone is present in a concentration between 0.1 and 5.5 g/l.
    6. Method for developing an image-wise exposed photographic material, comprising a support and a silver halide emulsion layer, by means of a developer solution according to any of claims 1 to 5.
    7. Method according to claim 6 wherein there is no replenisher for said developing solution.
    8. Method according to claim 6 or 7 wherein the silver halide emulsion, present in said silver halide layer, contains at least 70 mole % of bromide.
    EP19930202545 1992-09-15 1993-08-31 An ascorbic acid type developer with a particular composition Expired - Lifetime EP0588408B1 (en)

    Applications Claiming Priority (2)

    Application Number Priority Date Filing Date Title
    EP92202809 1992-09-15
    EP92202809 1992-09-15

    Publications (2)

    Publication Number Publication Date
    EP0588408A1 EP0588408A1 (en) 1994-03-23
    EP0588408B1 true EP0588408B1 (en) 1998-05-13

    Family

    ID=8210916

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP19930202545 Expired - Lifetime EP0588408B1 (en) 1992-09-15 1993-08-31 An ascorbic acid type developer with a particular composition

    Country Status (2)

    Country Link
    EP (1) EP0588408B1 (en)
    DE (1) DE69318498T2 (en)

    Families Citing this family (11)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    JP3078431B2 (en) * 1993-09-27 2000-08-21 富士写真フイルム株式会社 Method for developing black-and-white silver halide photographic materials
    GB2292813B (en) * 1994-08-27 1999-02-03 Ilford Ltd Photographic silver halide developing solution
    EP0736802A1 (en) * 1995-04-04 1996-10-09 Minnesota Mining And Manufacturing Company Photographic silver halide developer composition and method
    US5942379A (en) * 1995-08-10 1999-08-24 Eastman Kodak Company 3-pyrazolidone compounds and photographic developer solutions containing same
    US5589323A (en) * 1996-01-23 1996-12-31 Sun Chemical Corporation Chemically stable ascorbate-based photographic developer and imaging process
    US5702875A (en) * 1996-06-28 1997-12-30 Eastman Kodak Company Weakly alkaline ascorbic acid developing composition, processing kit and method using same
    US5866309A (en) * 1997-10-22 1999-02-02 Fitterman; Alan S. Method for processing roomlight handleable photographic elements
    US5932398A (en) * 1997-11-14 1999-08-03 Eastman Kodak Company Kit for roomlight processing of black-and-white photographic elements
    US5871890A (en) * 1997-11-14 1999-02-16 Eastman Kodak Company Method for processing roomlight handleable radiographic films using two-stage development
    JP4865664B2 (en) 2007-09-28 2012-02-01 富士フイルム株式会社 Method of mixing two or more liquids in a porous carrier
    EP2065706B1 (en) 2007-11-29 2012-11-07 FUJIFILM Corporation Immunochromatography method

    Family Cites Families (4)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    BE530885A (en) * 1953-08-03
    GB2011103B (en) * 1977-12-15 1982-05-19 Agfa Gevaert Nv Photographic material for continuous tone reproduction
    JPH02304555A (en) * 1989-05-19 1990-12-18 Konica Corp Method for processing silver halide photographic sensitive material
    US5098819A (en) * 1990-01-31 1992-03-24 Knapp Audenried W Non-toxic photographic developer composition

    Also Published As

    Publication number Publication date
    DE69318498T2 (en) 1998-11-12
    DE69318498D1 (en) 1998-06-18
    EP0588408A1 (en) 1994-03-23

    Similar Documents

    Publication Publication Date Title
    EP0573700A1 (en) Replenishment of a developer containing ascorbic acid and 3-pyrazolidone derivatives
    EP0498968B1 (en) Photographic developing process utilizing an ascorbic acid derivative
    US4310622A (en) Photographic development process
    EP0588408B1 (en) An ascorbic acid type developer with a particular composition
    US3247201A (en) 1-carbocyclic aryl-2-tertiary amino-3, 4-hydrocarbon and carbocyclic aryl-3-pyrazolidones
    US5266442A (en) Method for increasing the contrast of photographic silver images
    USH2048H1 (en) Non-hydroquinone photographic developer composition with lith quality and its method of usage
    EP0071344B1 (en) Stable photographic developer and replenisher therefor
    EP0196705B1 (en) A method of effecting high contrast development of a image-wise exposed photographic silver halide emulsion layer material
    EP0382200B1 (en) Method for processing silver halide photographic materials
    EP0531582A1 (en) Stabilized ascorbic acid developer
    EP0450198B1 (en) Developer liquid for high contrast development
    US4741991A (en) Stable photographic developer and replenisher therefor
    EP0501546A1 (en) High contrast developer containing an aprotic solvent
    EP0529152B1 (en) A new class of masked stabilizers in photographic materials or developing solutions
    US5776666A (en) Triazolium thiolate baths for silver halide development acceleration
    JPH1069037A (en) Mercaptothiadiazoleglycerolpropoxylate and photographic developing composition containing the same
    EP1231504B1 (en) Photographic developing composition and use thereof in the development of a photographic element
    US5830626A (en) Photographic developing composition containing anti-sludging agent and use thereof
    JPS624703B2 (en)
    EP0758646B1 (en) Compounds of the 3-pyrazolidone type useful in photography
    EP0786697A1 (en) Chemically stable ascorbate-based photographic developer and imaging process
    EP0507145A1 (en) Alkaline black-and-white developer for silver halide photographic material
    EP0543576A1 (en) A developer composition and a method for forming an image which uses the same

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    AK Designated contracting states

    Kind code of ref document: A1

    Designated state(s): BE DE FR GB NL

    17P Request for examination filed

    Effective date: 19940822

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    17Q First examination report despatched

    Effective date: 19970909

    GRAG Despatch of communication of intention to grant

    Free format text: ORIGINAL CODE: EPIDOS AGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAH Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOS IGRA

    GRAA (expected) grant

    Free format text: ORIGINAL CODE: 0009210

    AK Designated contracting states

    Kind code of ref document: B1

    Designated state(s): BE DE FR GB NL

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: NL

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 19980513

    Ref country code: BE

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 19980513

    REF Corresponds to:

    Ref document number: 69318498

    Country of ref document: DE

    Date of ref document: 19980618

    ET Fr: translation filed
    NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: 746

    Effective date: 19981014

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: D6

    PLBE No opposition filed within time limit

    Free format text: ORIGINAL CODE: 0009261

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

    26N No opposition filed
    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FR

    Payment date: 20000705

    Year of fee payment: 8

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: GB

    Payment date: 20000710

    Year of fee payment: 8

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GB

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20010831

    GBPC Gb: european patent ceased through non-payment of renewal fee

    Effective date: 20010831

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: FR

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20020430

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: ST

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: DE

    Payment date: 20030620

    Year of fee payment: 11

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: DE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20050301